Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: MS

Glatiramer acetate in CIS

September 9, 2008

Laquinimod effects on MRI activity: results of a 36-week extension study

August 25, 2008

45

Browse by Topic

MS (442)
EAN 2026 (2)
CLINICAL CASES (21)
AAN 2026 (3)
ACTRIMS Forum 2026 (4)
EPILEPSY (38)
AES 2025 (1)
BIOMARKERS IN MS (61)
ECTRIMS 2025 (7)
Library (18)
EAN 2025 (2)
AAN 2025 (5)
ACTRIMS 2025 (6)
AES 2024 (1)
ECTRIMS 2024 (6)
EAN 2024 (3)
AD (85)
AAN 2024 (5)
ACTRIMS Forum 2024 (2)
PD (77)
COVID-19 (58)
MIGRAINE (25)
DEPRESSION (36)
STROKE (22)
SCHIZOPHRENIA (25)
DEMENTIA (10)
SLEEP (2)
PAIN (3)
BPD (4)
ALS (1)

Popular Posts

Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
Highlights of EAN 2026 – Part 1 posted on June 30, 2026
Proton pump inhibitors linked to neurological conditions posted on November 29, 2019

Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions